CEPI

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Pacts With Exscientia, BenevolentAI Wil

The world may be celebrating the fact that the COVID-19 pandemic is subsiding but experts have warned that it may be "foolhardy" to take your "eyes off the ball now” given the continually evolving var

The University of Texas MD Anderson Cancer Center and US/UK biotech Replay announced on 14 February that they are launching a new company, Syena, to advance research conducted at the cancer center o

Tiba, CEPI Strive To Plan Ahead For Next Pandemic Tiba Biotech LLC and CEPI (Coalition for Epidemic Preparedness Innovations) said on 12 January that they will partner to evaluate the Cambridge, M